ArticleCancer management and research2019

Cost-Effectiveness Analysis Of Pembrolizumab In The Treatment Of Advanced Recurrent Metastatic Head And Neck Squamous Cell Carcinoma In China And The United States.

Maobai Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.